Monolith Advisors »

Adaptive Biotechnologies Cor shares owned by Monolith Advisors

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Monolith Advisors from 13F filings

Historical chart of Monolith Advisors investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Monolith Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Monolith Advisors

Quarter filed Position value Share count Share price at filing
2022-09-30 $67k 9.4k 7.14
2022-06-30 $76k 9.4k 8.10
2022-03-31 $263k 9.4k 28.04
2021-12-31 $263k 9.4k 28.04

More positions owned by Monolith Advisors

Goldman Sachs Actvbeta Uit Exchange Traded (GSLC)
Goldman Sachs Acs Us Uit Exchange Traded (GCOR)
Goldman Sachs Marktbta Uit Exchange Traded (GSUS)
Goldman Sachs Actvbt Uit Exchange Traded (GSIE)
Gldmn Sch Actvbeta Us Uit Exchange Traded (GSSC)
Morgan Stanley Inst Glob Equity Funds (MGGIX)
Gldmn Schs Acs Inv Grd Uit Exchange Traded (GIGB)
Gldmn Sch Acs Infla Prtc Uit Exchange Traded (GTIP)
Morgan Stanley Inst Glob Equity Funds (MIGIX)
Goldman Sachs Acces Uit Exchange Traded (GBIL)
Spdr S&p 500 Etf Uit Exchange Traded (SPY)
Ishares Jpmorgan Usd Mts Uit Exchange Traded (EMB)
Spdr Gold Shares Etf Uit Exchange Traded (GLD)
Ishares S&p 500 Growth Uit Exchange Traded (IVW)
Spdr Long Term Treasury Uit Exchange Traded (SPTL)

View all positions for Monolith Advisors

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
Rubric Capital Management
BlackRock
ARK Investment Management
Vanguard Group
Millennium Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Aristotle Atlantic Partners
Massachusetts Financial Services
Geode Capital Management
State Street Corporation
Blue Water Life Science Advisors
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding Adaptive Biotechnologies Cor